FCSC—I’m LMAO that posters on other iHub boards are raving about laViv’s purported efficacy in burn victims insofar as there are no plans I’m aware of to seek FDA approval in such an indication. Touting potential approval in indications such as burns is a trick of the trade for sleazy biotech companies, and FCSC is no exception, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.